Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant activated Factor X variant |
---|---|
Date Designated: | 03/03/2015 |
Orphan Designation: | Treatment of intracerebral hemorrhage |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pfizer, Inc. 66 Hudson Boulevard East New York, New York 10001 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-